NDAQ vs STAA · P/E 41, rev $2.53B vs rev $187.1M
Nasdaq Inc (NDAQ) versus STAAR Surgical Company (STAA) — a side-by-side from cached financials, not a winner call.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
STAAR Surgical Company (STAA) is a medical instruments & supplies company listed on NASDAQ.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Latest reported STAA revenue for 2026-07-03 was $187.1M. Net income was $13.3M. STAA currently screens at market cap $1.45B.
NDAQ currently screens at market cap $51.71B and trailing P/E 40.8. STAA currently screens at market cap $1.45B.
Not investment advice. Open the NDAQ and STAA stock pages for the full models.
Not investment advice.